About this trial
The primary aim of this study is to evaluate the predictive value of the Amniotic-Umbilical-to-Cerebral Ratio (AUCR) in predicting composite adverse perinatal outcomes in women with hypertensive disorders of pregnancy and to compare its predictive performance with the traditional Cerebroplacental Ratio (CPR)
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Women aged 18-40 years, inclusive.
Singleton viable pregnancy.
Gestational age ≥32 weeks.
Pregnancy complicated by a hypertensive disorder.
Disqualifiers
Multiple gestation.
Fetuses with known chromosomal or major congenital anomalies.
Maternal diseases likely to independently affect fetal circulation or perinatal outcome, such as significant cardiac disease or other major systemic diseases.
Inability to complete the required follow-up.
Trial population
pregnant women with hypertensive disorder
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
number of cases with NICU admission
number of neonates admitted in neonatal care unit within 24 hours after delivery
Secondary outcomes
weight of birth
birth weight in grams after delivery
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: